Anna Vilella
Overview
Explore the profile of Anna Vilella including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
1060
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gualda-Gea J, Baron-Miras L, Bertran M, Vilella A, Tora-Rocamora I, Prat A
Front Med (Lausanne)
. 2025 Feb;
12:1529305.
PMID: 39911871
Background: Artificial Intelligence (AI) has made a strong entrance into different fields such as healthcare, but currently, medical degree curricula are not adapted to the changes that adopting these types...
2.
Garcia-Perez J, Borobia A, Perez-Olmeda M, Portoles A, Castano L, Campins-Arti M, et al.
iScience
. 2024 Sep;
27(9):110728.
PMID: 39286494
CombiVacS study has demonstrated a strong immune response of the heterologous ChAdOx1-S/BNT162b2 vaccine combination. The primary outcomes of the study were to assess the humoral immune response against SARS-CoV-2, 28 ...
3.
Pitart C, Piquet M, Burgwinkel T, Del Pino R, Rubio M, Aguilar M, et al.
Emerg Microbes Infect
. 2024 Aug;
13(1):2392659.
PMID: 39137261
Early detection of disseminating vancomycin-resistant (VREfm) in ICU wards is crucial for outbreak identification and the implementation of prompt infection control measures. Genotypic methods like pulsed-field gel electrophoresis (PFGE) and...
4.
Martin Perez C, Aguilar R, Jimenez A, Salmeron G, Canyelles M, Rubio R, et al.
BMC Med
. 2024 Mar;
22(1):103.
PMID: 38454385
Background: The emergence of new SARS-CoV-2 variants and the waning of immunity raise concerns about vaccine effectiveness and protection against COVID-19. While antibody response has been shown to correlate with...
5.
Perez-Muto V, Bertran M, Baron-Miras L, Tora-Rocamora I, Gualda-Gea J, Vilella A
Front Public Health
. 2024 Jan;
11:1297025.
PMID: 38259790
Background: Migrants are a vulnerable population at risk of worse health outcomes due to legal status, language barriers, and socioeconomic and cultural factors. Considering the conflicting literature on the subject,...
6.
Ayala-Borges B, Escobedo M, Egri N, Herrera S, Crespo M, Mirabet S, et al.
Vaccines (Basel)
. 2023 Dec;
11(12).
PMID: 38140248
The aim of the present study was to determine humoral and T-cell responses after four doses of mRNA-1273 vaccine in solid organ transplant (SOT) recipients, and to study predictors of...
7.
Blanco Y, Escudero D, Lleixa C, Llufriu S, Egri N, Garcia R, et al.
Neurol Neuroimmunol Neuroinflamm
. 2023 Sep;
10(6).
PMID: 37679040
Background And Objective: In people with multiple sclerosis (pwMS), concern for potential disease exacerbation or triggering of other autoimmune disorders contributes to vaccine hesitancy. We assessed the humoral and T-cell...
8.
Pazos M, Riera J, Moll-Udina A, Catala A, Narvaez S, Fuertes I, et al.
Ophthalmology
. 2023 Feb;
130(6):655-658.
PMID: 36804274
No abstract available.
9.
Cucchiari D, Egri N, Rodriguez-Espinosa D, Montagud-Marrahi E, Casals-Urquiza J, Del Risco-Zevallos J, et al.
Transplant Direct
. 2022 Oct;
8(11):e1389.
PMID: 36245998
Methods: Humoral (IgG/IgM) and cellular (N- and S-ELISpot) responses were studied in 117 kidney and 12 kidney-pancreas transplant recipients at the following time points: before the first dose, 14 d...
10.
Peiro-Mestres A, Fuertes I, Camprubi-Ferrer D, Marcos M, Vilella A, Navarro M, et al.
Euro Surveill
. 2022 Jul;
27(28).
PMID: 35837964
A monkeypox (MPX) outbreak has expanded worldwide since May 2022. We tested 147 clinical samples collected at different time points from 12 patients by real-time PCR. MPX DNA was detected...